Skip to content

Permacol Surgical Mesh

by Tissue Science Laboratories, Plc 3 variants

510(k) K021056

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK021056 Date31 Oct 2002ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Permacol
510(k) Number
FDA Product Code
FTM
Device Class
Class II
Regulation
21 CFR Part 878.3300
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Permacol is a crosslinked porcine dermal collagen mesh classified as a surgical mesh. It is designed to reinforce soft tissue where structural weakness exists and to repair damaged or ruptured soft tissue membranes, providing durable support during surgical procedures.

The device is supplied sterile and intended for single-use in surgical settings. It is classified as a Class II medical device under FDA regulations (21 CFR 878.3300) and has received 510(k) clearance for use in general plastic surgery. Available in various sizes, Permacol is intended for placement via laparoscopic or open surgical approaches and is not MRI-compatible.

Other devices from Tissue Science Laboratories, Plc

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of surgical procedures is Permacol designed to support, and how is it typically placed during surgery?

    Permacol is designed to reinforce soft tissue where structural weakness exists or to repair damaged or ruptured soft tissue membranes, providing durable support during surgical procedures. It is intended for use in general plastic surgery and can be placed via either laparoscopic or open surgical approaches. The mesh is specifically engineered to offer long-term reinforcement to tissues, making it suitable for procedures requiring stable, flexible reinforcement.

  • Is Permacol reusable, or is it intended for single-use only? How is it supplied?

    Permacol is explicitly intended for single-use in surgical settings. It is supplied sterile, ensuring it is ready for immediate use without requiring additional sterilization procedures. This design minimizes the risk of contamination and ensures patient safety.

  • What sizes are available for Permacol, and how do I determine the appropriate size for a patient?

    Permacol is available in various sizes, though the exact dimensions are not specified in the provided data. The selection of the appropriate size would depend on the specific anatomical requirements of the patient and the surgical procedure being performed. Consulting the manufacturer’s sizing guidelines or a surgical specialist is recommended to ensure proper fit and effectiveness.

  • Can Permacol be used in MRI scans, or does it pose any risks during imaging?

    Permacol is explicitly noted as not MRI-compatible. This means it should not be used in patients who require MRI imaging, as the mesh could interfere with the scan or pose safety risks during the procedure. Always verify compatibility with imaging requirements before use.

  • What is the regulatory pathway for Permacol, and how was its safety and effectiveness determined?

    Permacol underwent a 510(k) clearance process through the FDA, classified as a Class II medical device under 21 CFR 878.3300. The clearance was based on a determination of substantial equivalence to a predicate device, meaning its safety and effectiveness were compared to an already-approved surgical mesh. The device was reviewed by the Surgical Products (SU) Advisory Committee under the General, Plastic Surgery specialty.